Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by K. Vetter.
Nephron | 1990
Kristina Lindenau; Klaus Abendroth; Kokot F; K. Vetter; Christoph Rehse; Peter T. Fröhling
The therapeutical effect of keto acids on bone histology was investigated in a prospective randomized controlled study of 40 patients. A marked improvement in osteofibrotic as well as in osteomalacic changes was found in bone biopsies after 12 months of treatment with keto acids.
Nephron | 1980
Peter T. Fröhling; Kokot F; K. Vetter; Jadwiga Kuska; Ingrid Kaschube; Jerzy Pietrek
The present study was aimed at answering the following two questions: (1) What is the effect of high dose vitamin D treatment on the serum level of 25-hydroxyvitamin D (25-OH-D) in patients with chronic renal failure (CRF)? (2) Is there any effect of urinary protein loss on the serum 25-OH-D levels during treatment with pharmacological doses of vitamin D? 42 patients with CRF were studied. They were treated conservatively by a low protein diet and received 15 mg of vitamin D2 once a week. Long-term administration of vitamin D caused a significant (5- to 7-fold) increase of plasma 25-OH-D level irrespective of the degree of proteinuria. This increase was noted only during the first 5 months of vitamin D2 treatment. Surprisingly only in some patients moderate hypercalcemia (> 2.75 mmol/l) was found. From the results obtained it is concluded that (1) patients with CRF differ from normal subjects in handling of high doses of vitamin D and (2) high dosage treatment with vitamin D may prevent hypocalcemia in patients with CRF in spite of high proteinuria.
Contributions To Nephrology | 1988
Peter T. Fröhling; R. Schmicker; Kristina Lindenau; K. Vetter; Kokot F
KA administration given in addition to a low-protein diet leads to a reduction of PTH secretion followed by diminishing of osteofibrosis. Osteomalacia will also be reduced by a better control of the calcium-phosphate metabolism, an increase of 1,25-(OH)2-D levels, and a lower burden of aluminum. Therapeutic levels of 25-OH-D and calcitonin (caused by simultaneous administration of vitamin D) are probably necessary to achieve this effect. KA are not only the optimum form of substitution in the nutritional treatment of chronic renal failure, but they seem to be very effective in the treatment of renal osteodystrophy.
Contributions To Nephrology | 1990
Peter T. Fröhling; Ingrid Kaschube; K. Vetter; Elisabeth Knäbich; Kristina Lindenau; R. Schmicker
Contributions To Nephrology | 1988
Peter T. Fröhling; Kokot F; K. Vetter; Ingrid Kaschube; Kristina Lindenau; J. Pfitzner; R. Schmicker
Contributions To Nephrology | 1988
Kristina Lindenau; Kokot F; K. Vetter; Peter T. Fröhling; R. Schmicker; U. Futh; I. Grossmann
Contributions To Nephrology | 1986
P. T. Froehling; K. Kokot; K. Vetter; Ingrid Kaschube; Kristina Lindenau
Contributions To Nephrology | 1990
K. Vetter; Ingrid Kaschube; C. Metzner; Kristina Lindenau; Peter T. Fröhling
Nahrung-food | 1984
K. Vetter; Helga Gutschlag; G. Schmoz; Ingrid Kaschube; W. Lüder
Contributions To Nephrology | 1984
Peter T. Fröhling; Kokot F; K. Vetter; W. D. Hohmann; G. Werner; I. Grossmann; R. Schmicker; Kristina Lindenau